BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 70 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $12,000 | -40.0% | 5,934 | 0.0% | 0.00% | – |
| Q1 2019 | $20,000 | +17.6% | 5,934 | 0.0% | 0.00% | – |
| Q4 2018 | $17,000 | -54.1% | 5,934 | 0.0% | 0.00% | – |
| Q3 2018 | $37,000 | -15.9% | 5,934 | 0.0% | 0.00% | – |
| Q2 2018 | $44,000 | +29.4% | 5,934 | +13.4% | 0.00% | – |
| Q1 2018 | $34,000 | -41.4% | 5,235 | -24.7% | 0.00% | – |
| Q4 2017 | $58,000 | -27.5% | 6,948 | 0.0% | 0.00% | – |
| Q3 2017 | $80,000 | +19.4% | 6,948 | +21.2% | 0.00% | – |
| Q2 2017 | $67,000 | +15.5% | 5,733 | +20.8% | 0.00% | – |
| Q1 2017 | $58,000 | -14.7% | 4,746 | -3.8% | 0.00% | – |
| Q4 2016 | $68,000 | +21.4% | 4,932 | +72.7% | 0.00% | – |
| Q3 2016 | $56,000 | +55.6% | 2,856 | 0.0% | 0.00% | – |
| Q2 2016 | $36,000 | – | 2,856 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 220,000 | $5,069,000 | 3.43% |
| Perceptive Advisors | 1,046,402 | $24,109,000 | 2.02% |
| Redmile Group, LLC | 860,809 | $17,269,000 | 1.88% |
| Baker Brothers Advisors | 4,283,732 | $98,697,000 | 1.01% |
| RA Capital Management | 1,026,402 | $9,337,000 | 1.00% |
| Ghost Tree Capital, LLC | 75,000 | $1,728,000 | 0.83% |
| ACUTA CAPITAL PARTNERS, LLC | 45,750 | $1,054,000 | 0.71% |
| GREAT POINT PARTNERS LLC | 50,000 | $1,152,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 167,210 | $3,853,000 | 0.33% |
| EMERALD ADVISERS, LLC | 198,202 | $4,567,000 | 0.24% |